These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. siRNA delivery into tumor cells by lipid-based nanoparticles composed of hydroxyethylated cholesteryl triamine. Hattori Y; Nakamura T; Ohno H; Fujii N; Maitani Y Int J Pharm; 2013 Feb; 443(1-2):221-9. PubMed ID: 23279939 [TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes. Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333 [TBL] [Abstract][Full Text] [Related]
4. Enhanced plasmid DNA transfer into tumor cells by nanoparticle composed of cholesteryl triamine and diamine. Hattori Y; Nakamura T; Ohno H; Fujii N; Maitani Y Biol Pharm Bull; 2013; 36(5):856-60. PubMed ID: 23649342 [TBL] [Abstract][Full Text] [Related]
5. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes. Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847 [TBL] [Abstract][Full Text] [Related]
6. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex. Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300 [TBL] [Abstract][Full Text] [Related]
7. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. Zhang Y; Li H; Sun J; Gao J; Liu W; Li B; Guo Y; Chen J Int J Pharm; 2010 May; 390(2):198-207. PubMed ID: 20116418 [TBL] [Abstract][Full Text] [Related]
8. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery. Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577 [TBL] [Abstract][Full Text] [Related]
9. NaCl induced high cationic hydroxyethylated cholesterol-based nanoparticle-mediated synthetic small interfering RNA transfer into prostate carcinoma PC-3 cells. Hattori Y; Yoshizawa T; Koga K; Maitani Y Biol Pharm Bull; 2008 Dec; 31(12):2294-301. PubMed ID: 19043216 [TBL] [Abstract][Full Text] [Related]
10. Highly efficient cationic hydroxyethylated cholesterol-based nanoparticle-mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells. Hattori Y; Ding WX; Maitani Y J Control Release; 2007 Jul; 120(1-2):122-30. PubMed ID: 17512626 [TBL] [Abstract][Full Text] [Related]
11. Effect of Cationic Lipid Type in Folate-PEG-Modified Cationic Liposomes on Folate Receptor-Mediated siRNA Transfection in Tumor Cells. Hattori Y; Shimizu S; Ozaki KI; Onishi H Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30991703 [TBL] [Abstract][Full Text] [Related]
12. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy. Lee J; Ahn HJ Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442 [TBL] [Abstract][Full Text] [Related]
13. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy. Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990 [TBL] [Abstract][Full Text] [Related]
14. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts. Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery. Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204 [TBL] [Abstract][Full Text] [Related]
16. Effect of lipid composition on the structure and theoretical phase diagrams of DC-Chol/DOPE-DNA lipoplexes. Muñoz-Ubeda M; Rodríguez-Pulido A; Nogales A; Martín-Molina A; Aicart E; Junquera E Biomacromolecules; 2010 Dec; 11(12):3332-40. PubMed ID: 21058732 [TBL] [Abstract][Full Text] [Related]
17. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245 [TBL] [Abstract][Full Text] [Related]
18. Development of non-viral vector for cancer gene therapy. Hattori Y Yakugaku Zasshi; 2010 Jul; 130(7):917-23. PubMed ID: 20606371 [TBL] [Abstract][Full Text] [Related]
19. Anionic amino acid-derived cationic lipid for siRNA delivery. Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256 [TBL] [Abstract][Full Text] [Related]
20. Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes. Hattori Y; Saito H; Oku T; Ozaki KI Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]